1. Home
  2. BMRN vs POOL Comparison

BMRN vs POOL Comparison

Compare BMRN & POOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • POOL
  • Stock Information
  • Founded
  • BMRN 1996
  • POOL 1993
  • Country
  • BMRN United States
  • POOL United States
  • Employees
  • BMRN N/A
  • POOL N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • POOL Industrial Specialties
  • Sector
  • BMRN Health Care
  • POOL Consumer Discretionary
  • Exchange
  • BMRN Nasdaq
  • POOL Nasdaq
  • Market Cap
  • BMRN 11.3B
  • POOL 11.6B
  • IPO Year
  • BMRN 1999
  • POOL 1995
  • Fundamental
  • Price
  • BMRN $57.77
  • POOL $333.09
  • Analyst Decision
  • BMRN Buy
  • POOL Hold
  • Analyst Count
  • BMRN 23
  • POOL 7
  • Target Price
  • BMRN $93.14
  • POOL $346.43
  • AVG Volume (30 Days)
  • BMRN 1.8M
  • POOL 475.0K
  • Earning Date
  • BMRN 10-28-2025
  • POOL 10-23-2025
  • Dividend Yield
  • BMRN N/A
  • POOL 1.50%
  • EPS Growth
  • BMRN 154.69
  • POOL N/A
  • EPS
  • BMRN 3.40
  • POOL 10.81
  • Revenue
  • BMRN $3,063,608,000.00
  • POOL $5,276,415,000.00
  • Revenue This Year
  • BMRN $13.32
  • POOL $1.96
  • Revenue Next Year
  • BMRN $9.37
  • POOL $3.73
  • P/E Ratio
  • BMRN $16.97
  • POOL $30.75
  • Revenue Growth
  • BMRN 18.36
  • POOL N/A
  • 52 Week Low
  • BMRN $52.93
  • POOL $282.22
  • 52 Week High
  • BMRN $90.01
  • POOL $395.60
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 48.39
  • POOL 61.71
  • Support Level
  • BMRN $55.99
  • POOL $299.99
  • Resistance Level
  • BMRN $59.79
  • POOL $328.29
  • Average True Range (ATR)
  • BMRN 1.37
  • POOL 8.76
  • MACD
  • BMRN -0.05
  • POOL 0.10
  • Stochastic Oscillator
  • BMRN 46.84
  • POOL 95.64

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

Share on Social Networks: